Arcutis Biotherapeutics, Inc. (ARQT) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the Arcudous Biotherapeutics 2025 Third Quarter Financial Results and Investor Day presentation. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To submit questions, please use the question submission field located at the bottom of your webcast interface. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Brian Shawcoff, Head of Investor Relations. Please go ahead. Thank you. Good morning, everyone. And thank you for joining us today to review our third quarter 2025 financial results and business update. And for our extended investor day presentation. Slides for today's call are available in the investor section of the Arcutus website. Joining me on the call today are Frank Watanabe, President and CEO of Arcutis, Todd Edwards, Chief Commercial Officer, Patrick Burnett, Chief Medical Officer, and Mata Varavan, Chief Financial Officer. We will also be joined later in the call by Douglas DeRiggiero, a Certified Physician Assistant and Doctor of Medical Science who has specialized in dermatology for the past 25 years and is the founding president of the Georgia Dermatology Physician Assistance Society. I would like to remind everyone that we will be making forward looking statements during this call. These statements are subject to certain risks and uncertainties and our actual results may differ. We encourage you to review all the company's filings with the Securities and Exchange Commission, including descriptions of our business and risk factors. With that, let me hand it over to Frank for a brief introduction of today's call. Thanks, Brian, and t...